PF-Atlas › Clinical Trials › NCT00001959

Pirfenidone to Treat Kidney Disease

Pirfenidone · Phase 2

Registry ID
NCT00001959
Phase
Phase 2
Status
Completed
Drug / intervention
Pirfenidone
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Start
1999-12

About this trial

Pirfenidone is evaluated in NCT00001959, a Phase 2 idiopathic pulmonary fibrosis study sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Current status: Completed.

View NCT00001959 on ClinicalTrials.gov →

Explore related

All Pirfenidone trialsAll IPF trials

Related trials

pirfenidone — NCT00662038Pirfenidone — NCT02951429Pirfenidone — NCT00287729Pirfenidone — NCT01504334Pirfenidone — NCT02932566Pirfenidone — NCT00287716
Medical disclaimer. This page summarizes public trial data for NCT00001959 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.